Trial intelligence / Profile preview

Duloxetine PK in Post-Bariatric Surgery Patients

NCT00989157Phase 3Completed

Sponsor
Neuropsychiatric Research Institute
Start
Sep 2009
Primary completion
Oct 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of duloxetine in major depressive disorder (MDD), sponsored by Neuropsychiatric Research Institute. Started Sep 2009; status: completed.

02

Drugs

duloxetine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00989157.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00989157.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call